Also, administration of other IDO inhibitors may be effective in inhibiting the IDO-dependent angiogenesis in lung cancer, as well as in other malignancies, providing a potential solution in preventing the processes of tumor growth and metastasis [175,176]. This evidence concerns the gene IDO1 and lung carcinoma.